[A cancer vaccine comprised of peptides derived from the extracellular domain of the tumor-associated antigen Her-2/neu with potential antineoplastic activity. HER-2/neu peptide vaccine may induce antibodies with anti-tumor activity and may also elicit a specific CD8 T-cell response against specific tumor cell types. (NCI04) ( NCI )]
UMLS (NCI) C0879250HER-2/neu Peptide Vaccine
HER-2-Neu Peptide Vaccine
- Amino Acid, Peptide, or Protein
- Pharmacologic Substance
- Immunologic Factor